MARKET WIRE NEWS

MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-10 23:57:03 ET

MaxCyte, Inc. (MXCT)

Q1 2025 Earnings Conference Call

May 07, 2025, 04:30 PM ET

Company Participants

Eric Abdel - IR

Maher Masoud - President and CEO

Doug Swirsky - CFO

Conference Call Participants

Matt Larew - William Blair

Julie Simmonds - Panmure Liberum

Mark Massaro - BTIG

Chad Wiatrowski - TD Cowen

Dan Arias - Stifel

Presentation

Operator

Good day and thank you for standing by. Welcome to the MaxCyte First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Eric Abdel, Investor Relations. Please go ahead.

Eric Abdel

Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MaxCyte, we have Maher Masoud, President and Chief Executive Officer, and Douglas Swirsky, Chief Financial Officer.

Earlier today, MaxCyte released financial results for the first quarter ended March 31, 2025. A copy of the press release is available on the company's website. Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meaning of federal security laws. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.

Actual results may differ materially from those expressed or implied in any forward-looking statements due to a variety of factors, which are discussed in detail in our SEC filings, except as required by applicable law, the company has no obligation to publicly update any forward-looking statements, whether because of new information, future events, or otherwise.

And with that, I will turn the call over to Maher.

Maher Masoud

Thank you, Eric. Good afternoon, everyone, and thank you for joining MaxCyte's first quarter 2025 earnings call. Before discussing our business performance, I would like to take a little time to discuss the current environment....

Read the full article on Seeking Alpha

For further details see:

MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call Transcript
MaxCyte Inc.

NASDAQ: MXCT

MXCT Trading

-7.28% G/L:

$1.0199 Last:

198,764 Volume:

$1.09 Open:

mwn-ts Ad 300

MXCT Latest News

MXCT Stock Data

$82,138,988
103,153,769
1.05%
195
N/A
Biotechnology & Life Sciences
Healthcare
US
Rockville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App